How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

A decision tree regression system incorporates a set of if-then rules to predict a single numeric value. Decision tree regression is rarely used by itself because it overfits the training data, and so ...

Welcome everybody to Recursion's Earnings Call. I'm Chris Gibson, Co-Founder and CEO, and I'm excited to take you through Recursions 2024, 2025 and the time ahead. So with that we'll jump into the ...

🟣 Stack Data Structure interview questions and answers to help you prepare for your next data structures and algorithms interview in 2025.

Abstract: In this paper, the efficient recursive structure for computing arbitrary length M-dimensional (M-D) discrete cosine transform (DCT) is proposed. The M-D DCT are first converted into ...

Recursion Pharmaceuticals. has been granted a patent for a method to identify target proteins using a test ligand. The process involves docking simulations, molecular data extraction, and binding site ...

Recursion Pharmaceuticals has agreed to acquire the Oxford, U.K.-based artificial intelligence (AI) drug pioneer Exscientia, the companies said today, in a deal that consolidates two leaders in ...

Abstract: Where speed of computation, i.e. data throughput, is not a constraint, it is feasible to implement digital signal processing algorithms in a bit serial fashion. One could employ look-up ...

Recursion, a biopharma company, uses a data-driven approach to drug discovery, launching four clinical trials and planning a fifth in oncology. Recursion's software platform, the Recursion OS, is used ...